Palatin to Report First Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on November 15, 2021
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Palatin Technologies (NYSE American: PTN) will announce its Q1 FY 2022 operating results on November 15, 2021, before U.S. market opening. A conference call will follow at 9:30 a.m. ET, including a review of results and updates on development programs. The results press release will be issued at 7:30 a.m. ET, with a replay available until November 22, 2021. Interested parties can access the audio webcast through Palatin's website.
Details
News Market Reaction – PTN
The recorded move for PTN in the trading session of this news was -0.76%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CRANBURY, N.J., Nov. 10, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its first quarter, fiscal year 2022 operating results on Monday, November 15, 2021, before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November 15, 2021, at 9:30 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast
Q1 Fiscal Year 2022 Results Press Release | 11/15/2021 at 7:30 a.m. ET |
Q1 Fiscal Year 2022 Conference Call-Live | 11/15/2021 at 9:30 a.m. ET |
US/Canada Dial-In Number: | 1-877-614-0009 |
International Dial-In Number: | 1-856-344-9283 |
Conference ID: | 3594800 |
Q1 Fiscal Year 2022 Conference Call-Replay | 11/15/2021-11/22/2021 |
US/Canada Dial-In Number: | 1-888-203-1112 |
International Dial-In Number: | 1-719-457-0820 |
Replay Passcode: | 3594800 |
Audio Webcast Live and Replay Access | http://www.palatin.com |
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com.
About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-first-quarter-fiscal-year-2022-results-teleconference-and-webcast-to-be-held-on-november-15-2021-301421631.html
SOURCE Palatin Technologies, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.